Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

Anebulo Pharmaceuticals, Inc. Common Stock · ANEB

ANEBOTCCommon stockCurrentCIK 1815974Updated Nov 18, 2026

Company: Anebulo Pharmaceuticals, Inc. →

ANEB price & chart

Provider market data

Loading TradingView…

OTC:ANEB on TradingView ↗

TradingView · Data may be delayed

About the company

Anebulo Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing novel solutions for people suffering from cannabis-induced toxicity. Its lead product candidate, selonabant, has completed a Phase 2 clinical trial evaluating its utility in blocking and reversing the negative effects of acute cannabinoid intoxication in healthy adults challenged with oral THC. Rather than proceeding directly with Phase 3 studies of oral selonabant in adults with ACI, the Company is prioritizing the advancement of a selonabant IV formulation as a potential treatment for pediatric patients with acute cannabis-induced toxicity, which it believes offers the potential for a faster timeline to approval relative to the adult oral product. Anebulo has scaled up the intravenous formulation for initial clinical safety studies, and initiated a Phase 1 SAD study of IV selonabant in September 2025. Selonabant is a competitive antagonist at the human CB1 receptor. For further information about Anebulo, please visit www.anebulo.com.

8-K · 2025-11-13 · 0001493152-25-022310

Company description from the cited filing.

Financials

FY 2025 · USD
Revenue— · FY 2025
Net income-8,484,763USD · FY 2025
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

Operating income-9,223,481USD · FY 2025
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

Diluted EPS-0.25USD per share · FY 2025
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD14,008,484
Source

10-Q · 2025-05-13 · 0001641172-25-009975

As of 2025-03-31

5,995,635
Source

10-Q · 2024-05-15 · 0001493152-24-019922

As of 2024-03-31

9,421,997
Source

10-Q · 2026-02-12 · 0001493152-26-006446

As of 2025-12-31

15,841,220
Source

10-Q · 2025-02-14 · 0001493152-25-006893

As of 2024-12-31

7,500,773
Source

10-Q · 2024-02-13 · 0001493152-24-006103

As of 2023-12-31

10,701,039
Source

10-Q · 2025-11-13 · 0001493152-25-022350

As of 2025-09-30

2,467,940
Source

10-Q · 2024-11-13 · 0001493152-24-045151

As of 2024-09-30

9,047,884
Source

10-Q · 2023-11-14 · 0001493152-23-041171

As of 2023-09-30

12,145,616
Source

10-K · 2025-09-29 · 0001493152-25-016015

As of 2025-06-30

4,073,114
Source

10-K · 2024-09-25 · 0001493152-24-038127

As of 2024-06-30

11,670,151
Source

10-K · 2023-09-22 · 0001493152-23-033452

As of 2023-06-30

15,579,431
Source

10-K · 2022-09-09 · 0001493152-22-025448

As of 2022-06-30

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD13,279,901
Source

10-Q · 2025-05-13 · 0001641172-25-009975

As of 2025-03-31

5,147,139
Source

10-Q · 2024-05-15 · 0001493152-24-019922

As of 2024-03-31

9,041,570
Source

10-Q · 2026-02-12 · 0001493152-26-006446

As of 2025-12-31

14,998,467
Source

10-Q · 2025-02-14 · 0001493152-25-006893

As of 2024-12-31

6,644,517
Source

10-Q · 2024-02-13 · 0001493152-24-006103

As of 2023-12-31

10,354,773
Source

10-Q · 2025-11-13 · 0001493152-25-022350

As of 2025-09-30

1,404,211
Source

10-Q · 2024-11-13 · 0001493152-24-045151

As of 2024-09-30

8,520,578
Source

10-Q · 2023-11-14 · 0001493152-23-041171

As of 2023-09-30

11,627,849
Source

10-K · 2025-09-29 · 0001493152-25-016015

As of 2025-06-30

3,094,200
Source

10-K · 2024-09-25 · 0001493152-24-038127

As of 2024-06-30

——
Assets, CurrentUSD13,807,935
Source

10-Q · 2025-05-13 · 0001641172-25-009975

As of 2025-03-31

5,370,815
Source

10-Q · 2024-05-15 · 0001493152-24-019922

As of 2024-03-31

9,273,766
Source

10-Q · 2026-02-12 · 0001493152-26-006446

As of 2025-12-31

15,395,489
Source

10-Q · 2025-02-14 · 0001493152-25-006893

As of 2024-12-31

6,816,257
Source

10-Q · 2024-02-13 · 0001493152-24-006103

As of 2023-12-31

10,535,369
Source

10-Q · 2025-11-13 · 0001493152-25-022350

As of 2025-09-30

1,962,513
Source

10-Q · 2024-11-13 · 0001493152-24-045151

As of 2024-09-30

—11,962,506
Source

10-K · 2025-09-29 · 0001493152-25-016015

As of 2025-06-30

3,507,990
Source

10-K · 2024-09-25 · 0001493152-24-038127

As of 2024-06-30

——
Other Assets, NoncurrentUSD200,549
Source

10-Q · 2025-05-13 · 0001641172-25-009975

As of 2025-03-31

624,820
Source

10-Q · 2024-05-15 · 0001493152-24-019922

As of 2024-03-31

148,231
Source

10-Q · 2026-02-12 · 0001493152-26-006446

As of 2025-12-31

445,731
Source

10-Q · 2025-02-14 · 0001493152-25-006893

As of 2024-12-31

684,516
Source

10-Q · 2024-02-13 · 0001493152-24-006103

As of 2023-12-31

165,670
Source

10-Q · 2025-11-13 · 0001493152-25-022350

As of 2025-09-30

505,427
Source

10-Q · 2024-11-13 · 0001493152-24-045151

As of 2024-09-30

—183,110
Source

10-K · 2025-09-29 · 0001493152-25-016015

As of 2025-06-30

565,124
Source

10-K · 2024-09-25 · 0001493152-24-038127

As of 2024-06-30

——
LIABILITIES AND EQUITY
LiabilitiesUSD546,032
Source

10-Q · 2025-05-13 · 0001641172-25-009975

As of 2025-03-31

1,010,321
Source

10-Q · 2024-05-15 · 0001493152-24-019922

As of 2024-03-31

1,485,646
Source

10-Q · 2026-02-12 · 0001493152-26-006446

As of 2025-12-31

878,799
Source

10-Q · 2025-02-14 · 0001493152-25-006893

As of 2024-12-31

1,013,556
Source

10-Q · 2024-02-13 · 0001493152-24-006103

As of 2023-12-31

963,821
Source

10-Q · 2025-11-13 · 0001493152-25-022350

As of 2025-09-30

569,225
Source

10-Q · 2024-11-13 · 0001493152-24-045151

As of 2024-09-30

716,560
Source

10-Q · 2023-11-14 · 0001493152-23-041171

As of 2023-09-30

487,688
Source

10-K · 2025-09-29 · 0001493152-25-016015

As of 2025-06-30

260,583
Source

10-K · 2024-09-25 · 0001493152-24-038127

As of 2024-06-30

1,068,801
Source

10-K · 2023-09-22 · 0001493152-23-033452

As of 2023-06-30

512,531
Source

10-K · 2022-09-09 · 0001493152-22-025448

As of 2022-06-30

Stockholders’ equity:
Common Stock, Value, IssuedUSD41,086
Source

10-Q · 2025-05-13 · 0001641172-25-009975

As of 2025-03-31

25,934
Source

10-Q · 2024-05-15 · 0001493152-24-019922

As of 2024-03-31

41,086
Source

10-Q · 2026-02-12 · 0001493152-26-006446

As of 2025-12-31

41,086
Source

10-Q · 2025-02-14 · 0001493152-25-006893

As of 2024-12-31

25,934
Source

10-Q · 2024-02-13 · 0001493152-24-006103

As of 2023-12-31

41,086
Source

10-Q · 2025-11-13 · 0001493152-25-022350

As of 2025-09-30

25,934
Source

10-Q · 2024-11-13 · 0001493152-24-045151

As of 2024-09-30

25,634
Source

10-Q · 2023-11-14 · 0001493152-23-041171

As of 2023-09-30

41,086
Source

10-K · 2025-09-29 · 0001493152-25-016015

As of 2025-06-30

25,934
Source

10-K · 2024-09-25 · 0001493152-24-038127

As of 2024-06-30

25,634
Source

10-K · 2023-09-22 · 0001493152-23-033452

As of 2023-06-30

23,345
Source

10-K · 2022-09-09 · 0001493152-22-025448

As of 2022-06-30

Additional Paid in CapitalUSD85,165,045
Source

10-Q · 2025-05-13 · 0001641172-25-009975

As of 2025-03-31

69,013,155
Source

10-Q · 2024-05-15 · 0001493152-24-019922

As of 2024-03-31

85,941,523
Source

10-Q · 2026-02-12 · 0001493152-26-006446

As of 2025-12-31

84,988,845
Source

10-Q · 2025-02-14 · 0001493152-25-006893

As of 2024-12-31

68,861,516
Source

10-Q · 2024-02-13 · 0001493152-24-006103

As of 2023-12-31

85,742,993
Source

10-Q · 2025-11-13 · 0001493152-25-022350

As of 2025-09-30

69,477,261
Source

10-Q · 2024-11-13 · 0001493152-24-045151

As of 2024-09-30

67,988,554
Source

10-Q · 2023-11-14 · 0001493152-23-041171

As of 2023-09-30

85,505,349
Source

10-K · 2025-09-29 · 0001493152-25-016015

As of 2025-06-30

69,190,341
Source

10-K · 2024-09-25 · 0001493152-24-038127

As of 2024-06-30

67,777,757
Source

10-K · 2023-09-22 · 0001493152-23-033452

As of 2023-06-30

60,513,258
Source

10-K · 2022-09-09 · 0001493152-22-025448

As of 2022-06-30

Retained Earnings (Accumulated Deficit)USD-71,743,679
Source

10-Q · 2025-05-13 · 0001641172-25-009975

As of 2025-03-31

-64,053,775
Source

10-Q · 2024-05-15 · 0001493152-24-019922

As of 2024-03-31

-78,046,258
Source

10-Q · 2026-02-12 · 0001493152-26-006446

As of 2025-12-31

-70,067,510
Source

10-Q · 2025-02-14 · 0001493152-25-006893

As of 2024-12-31

-62,400,233
Source

10-Q · 2024-02-13 · 0001493152-24-006103

As of 2023-12-31

-76,046,861
Source

10-Q · 2025-11-13 · 0001493152-25-022350

As of 2025-09-30

-67,604,480
Source

10-Q · 2024-11-13 · 0001493152-24-045151

As of 2024-09-30

-59,682,864
Source

10-Q · 2023-11-14 · 0001493152-23-041171

As of 2023-09-30

-73,888,507
Source

10-K · 2025-09-29 · 0001493152-25-016015

As of 2025-06-30

-65,403,744
Source

10-K · 2024-09-25 · 0001493152-24-038127

As of 2024-06-30

-57,202,041
Source

10-K · 2023-09-22 · 0001493152-23-033452

As of 2023-06-30

-45,469,703
Source

10-K · 2022-09-09 · 0001493152-22-025448

As of 2022-06-30

Stockholders' Equity Attributable to ParentUSD13,462,452
Source

10-Q · 2025-05-13 · 0001641172-25-009975

As of 2025-03-31

4,985,314
Source

10-Q · 2025-05-13 · 0001641172-25-009975

As of 2024-03-31

7,936,351
Source

10-Q · 2026-02-12 · 0001493152-26-006446

As of 2025-12-31

14,962,421
Source

10-Q · 2026-02-12 · 0001493152-26-006446

As of 2024-12-31

6,487,217
Source

10-Q · 2025-02-14 · 0001493152-25-006893

As of 2023-12-31

9,737,218
Source

10-Q · 2025-11-13 · 0001493152-25-022350

As of 2025-09-30

1,898,715
Source

10-Q · 2025-11-13 · 0001493152-25-022350

As of 2024-09-30

8,331,324
Source

10-Q · 2024-11-13 · 0001493152-24-045151

As of 2023-09-30

11,657,928
Source

10-K · 2025-09-29 · 0001493152-25-016015

As of 2025-06-30

3,812,531
Source

10-K · 2024-09-25 · 0001493152-24-038127

As of 2024-06-30

10,601,350
Source

10-K · 2023-09-22 · 0001493152-23-033452

As of 2023-06-30

15,066,900
Source

10-K · 2022-09-09 · 0001493152-22-025448

As of 2022-06-30

Liabilities and EquityUSD14,008,484
Source

10-Q · 2025-05-13 · 0001641172-25-009975

As of 2025-03-31

5,995,635
Source

10-Q · 2024-05-15 · 0001493152-24-019922

As of 2024-03-31

9,421,997
Source

10-Q · 2026-02-12 · 0001493152-26-006446

As of 2025-12-31

15,841,220
Source

10-Q · 2025-02-14 · 0001493152-25-006893

As of 2024-12-31

7,500,773
Source

10-Q · 2024-02-13 · 0001493152-24-006103

As of 2023-12-31

10,701,039
Source

10-Q · 2025-11-13 · 0001493152-25-022350

As of 2025-09-30

2,467,940
Source

10-Q · 2024-11-13 · 0001493152-24-045151

As of 2024-09-30

9,047,884
Source

10-Q · 2023-11-14 · 0001493152-23-041171

As of 2023-09-30

12,145,616
Source

10-K · 2025-09-29 · 0001493152-25-016015

As of 2025-06-30

4,073,114
Source

10-K · 2024-09-25 · 0001493152-24-038127

As of 2024-06-30

11,670,151
Source

10-K · 2023-09-22 · 0001493152-23-033452

As of 2023-06-30

15,579,431
Source

10-K · 2022-09-09 · 0001493152-22-025448

As of 2022-06-30

Current liabilities:
Accounts Payable, CurrentUSD427,578
Source

10-Q · 2025-05-13 · 0001641172-25-009975

As of 2025-03-31

384,920
Source

10-Q · 2024-05-15 · 0001493152-24-019922

As of 2024-03-31

554,862
Source

10-Q · 2026-02-12 · 0001493152-26-006446

As of 2025-12-31

319,515
Source

10-Q · 2025-02-14 · 0001493152-25-006893

As of 2024-12-31

318,679
Source

10-Q · 2024-02-13 · 0001493152-24-006103

As of 2023-12-31

607,539
Source

10-Q · 2025-11-13 · 0001493152-25-022350

As of 2025-09-30

252,142
Source

10-Q · 2024-11-13 · 0001493152-24-045151

As of 2024-09-30

565,949
Source

10-Q · 2023-11-14 · 0001493152-23-041171

As of 2023-09-30

224,175
Source

10-K · 2025-09-29 · 0001493152-25-016015

As of 2025-06-30

156,426
Source

10-K · 2024-09-25 · 0001493152-24-038127

As of 2024-06-30

534,545
Source

10-K · 2023-09-22 · 0001493152-23-033452

As of 2023-06-30

380,828
Source

10-K · 2022-09-09 · 0001493152-22-025448

As of 2022-06-30

Additional Financial Items
Accrued Liabilities, CurrentUSD118,454
Source

10-Q · 2025-05-13 · 0001641172-25-009975

As of 2025-03-31

625,401
Source

10-Q · 2024-05-15 · 0001493152-24-019922

As of 2024-03-31

930,784
Source

10-Q · 2026-02-12 · 0001493152-26-006446

As of 2025-12-31

559,284
Source

10-Q · 2025-02-14 · 0001493152-25-006893

As of 2024-12-31

694,877
Source

10-Q · 2024-02-13 · 0001493152-24-006103

As of 2023-12-31

356,282
Source

10-Q · 2025-11-13 · 0001493152-25-022350

As of 2025-09-30

317,083
Source

10-Q · 2024-11-13 · 0001493152-24-045151

As of 2024-09-30

150,611
Source

10-Q · 2023-11-14 · 0001493152-23-041171

As of 2023-09-30

263,513
Source

10-K · 2025-09-29 · 0001493152-25-016015

As of 2025-06-30

104,157
Source

10-K · 2024-09-25 · 0001493152-24-038127

As of 2024-06-30

534,256
Source

10-K · 2023-09-22 · 0001493152-23-033452

As of 2023-06-30

131,703
Source

10-K · 2022-09-09 · 0001493152-22-025448

As of 2022-06-30

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Share-based Payment Arrangement, Noncash ExpenseUSD——300,000
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

200,000
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

198,530
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

564,333
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

237,644
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

286,920
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

1,446,824
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

758,884
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

884,723
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

480,661
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts PayableUSD——————383,364
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

95,716
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

67,749
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

-378,119
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

153,717
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

270,780
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Net Cash Provided by (Used in) Operating ActivitiesUSD——————-1,273,076
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

-1,689,989
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

-6,349,687
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

-8,090,849
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

-9,683,133
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

-5,437,174
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD————————14,883,336
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

-62,354
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

6,382,065
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

—
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-1,273,076
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

-1,689,989
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

8,533,649
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

-8,153,203
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

-3,301,068
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

-5,437,174
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Additional Financial Items
Amortization of Debt Issuance CostsUSD——————17,440
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

59,697
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

382,014
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

151,230
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

——
General and Administrative ExpenseUSD——1,253,998
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

915,912
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

1,455,173
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

1,367,616
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

1,450,269
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

1,097,265
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

4,923,540
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

4,759,818
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

6,183,402
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

3,869,636
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

InterestExpenseNonoperatingUSD——245,182
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

59,696
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

17,439
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

59,696
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

17,439
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

59,697
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

382,014
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

151,230
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

——
Net Income (Loss) Attributable to ParentUSD——-1,676,169
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

-1,653,542
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

-1,999,397
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

-2,463,030
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

-2,158,354
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

-2,200,736
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

-8,484,763
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

-8,201,703
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

-11,732,338
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

-6,825,619
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Net Income (Loss) Available to Common Stockholders, BasicUSD———————————-6,825,619
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Nonoperating Income (Expense)USD——216,153
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

10,709
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

620,513
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

125,121
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

101,906
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

211,388
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

738,718
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

107,052
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

51,261
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

5,555
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Operating ExpensesUSD——1,892,322
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

1,664,251
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

2,619,910
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

2,588,151
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

2,260,260
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

2,412,124
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

9,223,481
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

8,308,755
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

11,783,599
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

6,831,174
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Other Nonoperating Income (Expense)USD——-528
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

2,321
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

-34
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

47
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

-96
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

-283
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

-1,195
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

9,260
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

-41,146
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

-1,777
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Payments of Financing CostsUSD————————116,664
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

———
Proceeds from Issuance of Common StockUSD————————15,000,000
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

—6,646,748
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

—
Proceeds from Stock Options ExercisedUSD——————————52,400
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

—

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Operating Income (Loss)USD——-1,892,322
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

-1,664,251
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

-2,619,910
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

-2,588,151
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

-2,260,260
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

-2,412,124
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

-9,223,481
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

-8,308,755
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

-11,783,599
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

-6,831,174
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Other Nonoperating Income (Expense)USD——-528
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

2,321
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

-34
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

47
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

-96
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

-283
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

-1,195
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

9,260
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

-41,146
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

-1,777
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Net Income (Loss) Attributable to ParentUSD——-1,676,169
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

-1,653,542
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

-1,999,397
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

-2,463,030
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

-2,158,354
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

-2,200,736
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

-8,484,763
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

-8,201,703
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

-11,732,338
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

-6,825,619
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Earnings Per Share, BasicUSD per share——-0.04
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

-0.06
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

-0.05
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

-0.09
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

-0.05
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

-0.08
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

-0.25
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

-0.32
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

0.47
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

-0.29
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Earnings Per Share, DilutedUSD per share——-0.04
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

-0.06
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

-0.05
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

-0.09
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

-0.05
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

-0.08
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

-0.25
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

-0.32
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

0.47
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

—
Weighted Average Number of Shares Outstanding, Basicshares——41,084,731
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

25,933,217
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

41,084,731
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

27,415,430
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

41,084,731
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

25,933,217
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

33,820,306
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

25,822,258
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

25,074,481
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

23,344,567
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Weighted Average Number of Shares Outstanding, Dilutedshares——41,084,731
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

25,933,217
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

41,084,731
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

27,415,430
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

41,084,731
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

25,933,217
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

33,820,306
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

25,822,258
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

25,074,481
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

—
Interest Expense (non-operating)USD——245,182
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

59,696
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

17,439
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

59,696
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

17,439
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

59,697
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

382,014
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

151,230
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

——
Additional Financial Items
General and Administrative ExpenseUSD——1,253,998
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

915,912
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

1,455,173
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

1,367,616
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

1,450,269
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

1,097,265
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

4,923,540
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

4,759,818
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

6,183,402
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

3,869,636
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Interest ExpenseUSD——100,000
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

59,696
Source

10-Q · 2024-05-15 · 0001493152-24-019922

2024-01-01 to 2024-03-31

17,000
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

100,000
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

17,000
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

100,000
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

400,000
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

———
Interest Income, OtherUSD——102,257
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

68,084
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

85,410
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

7,067
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

109,616
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

26,006
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

257,913
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

249,022
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

92,407
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

7,332
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Net Income (Loss) Available to Common Stockholders, BasicUSD———————————-6,825,619
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Nonoperating Income (Expense)USD——216,153
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

10,709
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

620,513
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

125,121
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

101,906
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

211,388
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

738,718
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

107,052
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

51,261
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

5,555
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Operating ExpensesUSD——1,892,322
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

1,664,251
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

2,619,910
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

2,588,151
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

2,260,260
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

2,412,124
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

9,223,481
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

8,308,755
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

11,783,599
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

6,831,174
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Research and Development ExpenseUSD——638,324
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2025-01-01 to 2025-03-31

748,339
Source

10-Q · 2025-05-13 · 0001641172-25-009975

2024-01-01 to 2024-03-31

1,164,737
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2025-10-01 to 2025-12-31

1,220,535
Source

10-Q · 2026-02-12 · 0001493152-26-006446

2024-10-01 to 2024-12-31

809,991
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2025-07-01 to 2025-09-30

1,314,859
Source

10-Q · 2025-11-13 · 0001493152-25-022350

2024-07-01 to 2024-09-30

4,299,941
Source

10-K · 2025-09-29 · 0001493152-25-016015

2024-07-01 to 2025-06-30

3,548,937
Source

10-K · 2024-09-25 · 0001493152-24-038127

2023-07-01 to 2024-06-30

5,600,197
Source

10-K · 2023-09-22 · 0001493152-23-033452

2022-07-01 to 2023-06-30

2,961,538
Source

10-K · 2022-09-09 · 0001493152-22-025448

2021-07-01 to 2022-06-30

Investment Income, Net————
Source

10-Q · 2024-05-15 · 0001493152-24-019922

2024-01-01 to 2024-03-31

————————

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

ex99-1.htm · 8-K · 2026-02-12

Exhibit 99.1 Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates AUSTIN, Texas (February 12, 2026) - Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or “Anebulo”), today announced financial results for the three months ended December 31, 2025, and recent updates. Second Quarter Fiscal Year 2026 and Subs…

8-K · 2026-02-12 · 0001493152-26-006428

Read attachment ↗
ex99-1.htm · 8-K · 2026-02-06

Exhibit 99.1 Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC AUSTIN, Texas (February 6, 2026) - Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or “Anebulo”), today announced that the Company’s board of directors (the “Board”) has approved the voluntary delisting of the Company’s common stock from Th…

8-K · 2026-02-06 · 0001493152-26-005463

Read attachment ↗
ex99-1.htm · 8-K · 2026-01-29

Exhibit 99.1 Anebulo Pharmaceuticals Announces Final Results of Tender Offer AUSTIN, Texas (January 29, 2026) - Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or “Anebulo”), today announced the final results of its voluntary self-tender offer to purchase 300,000 shares of its common stock, par value $0.001 per share (“Common Stock”), which expired one …

8-K · 2026-01-29 · 0001493152-26-004154

Read attachment ↗
ex99-1.htm · 8-K · 2026-01-27

Exhibit 99.1 Anebulo Pharmaceuticals Announces Preliminary Results of Tender Offer AUSTIN, Texas (January 27, 2026) - Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or “Anebulo”), today announced the preliminary results of its voluntary self-tender offer to purchase 300,000 shares of its common stock, par value $0.001 per share (“Common Stock”), which …

8-K · 2026-01-27 · 0001493152-26-003718

Read attachment ↗
ex99-1.htm · 8-K · 2025-12-22

EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Anebulo Pharmaceuticals Announces Its Intent to Commence a Self Tender Offer AUSTIN, Texas (December 22, 2025) - Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or “Anebulo”), today announced that the Board of Directors has decided to commence a cash tender offer as part of its plan to “go private” in lieu o…

8-K · 2025-12-22 · 0001493152-25-028676

Read attachment ↗
ex99-1.htm · 8-K · 2025-11-13

EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates AUSTIN, Texas (November 13, 2025) - Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or “Anebulo”), today announced financial results for the three months ended September 30, 2025, and recent updates. First Q…

8-K · 2025-11-13 · 0001493152-25-022310

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.